PHENOMEX INC (CELL) Stock Analyst Earnings Estimates
NASDAQ:CELL - Nasdaq - US0843101017 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 64.3M 13.42% | 85.39M 32.80% | 78.6M -7.95% | 78.029M -0.73% | 104.06M 33.36% | 135.93M 30.63% | 182.58M 34.32% | |
| EBITDA YoY % growth | -35.29M -201.62% | -65.19M -84.73% | -85.54M -31.22% | -78.23M 8.55% | -39.234M 49.85% | -28.764M 26.69% | N/A | |
| EBIT YoY % growth | -40.39M -144.20% | -70.79M -75.27% | -94.54M -33.55% | -91.213M 3.52% | -53.079M 41.81% | -44.166M 16.79% | N/A | |
| Operating Margin | -62.81% | -82.90% | -120.28% | -116.90% | -51.01% | -32.49% | N/A | |
| EPS YoY % growth | N/A | -1.07 5.78% | -1.43 -33.64% | -1.17 17.97% | -0.60 49.04% | -0.28 52.56% | -0.28 2.88% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.24 25.09% | -0.21 49.00% | -0.19 37.48% | -0.17 49.00% | -0.14 42.55% | -0.10 53.66% | -0.13 31.58% | -0.10 41.18% | -0.06 55.56% | -0.04 57.89% |
| Revenue Q2Q % growth | 19.964M -6.71% | 23.154M 29.79% | 20.388M 10.09% | 21.594M 53.58% | 25.361M 27.03% | 29.59M 27.80% | 27.54M 35.08% | 29.682M 37.45% | 33.864M 33.53% | 36.516M 23.41% |
| EBITDA Q2Q % growth | -21.687M -56.02% | -18.274M -0.19% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.684M -15.65% | -20.655M 24.17% | -18.617M 13.57% | -15.9M 46.21% | -10.635M 55.10% | -5.496M 73.39% | -12.095M 35.03% | -9.554M 39.91% | -5.399M 49.23% | -3.155M 42.59% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.34 10.53% | -0.34 | 0.00 | -1.01% |
| Q1 2023 Q2Q % growth | -0.31 3.13% | -0.30 | -0.01 | -4.80% |
| Q4 2022 Q2Q % growth | -0.41 -57.69% | -0.27 | -0.14 | -49.99% |
| Q3 2022 Q2Q % growth | -0.32 -6.67% | -0.30 | -0.02 | -5.28% |
| Q2 2022 Q2Q % growth | -0.38 -40.74% | -0.33 | -0.05 | -16.42% |
| Q1 2022 Q2Q % growth | -0.32 -33.33% | -0.32 | 0.00 | -0.55% |
| Q4 2021 Q2Q % growth | -0.26 -36.84% | -0.29 | 0.03 | 9.50% |
| Q3 2021 Q2Q % growth | -0.30 -87.50% | -0.25 | -0.05 | -21.70% |
| Q2 2021 Q2Q % growth | -0.27 93.65% | -0.24 | -0.03 | -10.29% |
| Q1 2021 Q2Q % growth | -0.24 | -0.25 | 0.01 | 3.57% |
| Q4 2020 Q2Q % growth | -0.19 | -0.20 | 0.01 | 6.08% |
| Q3 2020 Q2Q % growth | -0.16 | -0.20 | 0.04 | 20.78% |
| Q2 2020 Q2Q % growth | -4.25 | -0.19 | -4.06 | -2,092.98% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 14.06M -26.58% | 17.699M | -3.639M | -20.56% |
| Q1 2023 Q2Q % growth | 18.52M -8.36% | 18.238M | 282K | 1.55% |
| Q4 2022 Q2Q % growth | 17.84M -23.07% | 25.088M | -7.248M | -28.89% |
| Q3 2022 Q2Q % growth | 21.4M -12.01% | 22.016M | -616K | -2.80% |
| Q2 2022 Q2Q % growth | 19.15M -0.52% | 21.78M | -2.63M | -12.08% |
| Q1 2022 Q2Q % growth | 20.21M 8.48% | 20.624M | -414K | -2.01% |
| Q4 2021 Q2Q % growth | 23.19M 6.62% | 25.603M | -2.413M | -9.42% |
| Q3 2021 Q2Q % growth | 24.32M 33.55% | 23.52M | 800K | 3.40% |
| Q2 2021 Q2Q % growth | 19.25M 82.12% | 20.031M | -781K | -3.90% |
| Q1 2021 Q2Q % growth | 18.63M 35.20% | 16.942M | 1.688M | 9.96% |
| Q4 2020 Q2Q % growth | 21.75M | 19.421M | 2.329M | 11.99% |
| Q3 2020 Q2Q % growth | 18.21M | 15.597M | 2.613M | 16.75% |
| Q2 2020 Q2Q % growth | 10.57M | 10.549M | 21K | 0.20% |
| Q1 2020 Q2Q % growth | 13.78M 9.02% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |